Interestingly, both, breast cancer and healthy subjects showed wide distributions of the prevalence of beta-glucuronidase positivity, reaching from 0 to 33% in healthy controls and 0 to 49% in breast cancer subjects (Fig. 5C and D). This evidence concerns the gene GUSB and breast carcinoma.